327
Views
38
CrossRef citations to date
0
Altmetric
Methodology

An upper and lower bound of the Medication Possession Ratio

, &
Pages 1469-1478 | Published online: 30 Aug 2017

References

  • ClarkMALippincott’s Illustrated Reviews Pharmacology5th edBaltimore, MDWolters Kluwer Health/Lippincott Williams & Wilkins2012
  • SikkaRXiaFAubertREEstimating medication persistency using administrative claims dataAm J Manag Care200511744945716044982
  • CramerJABenedictAMuszbekNKeskinaslanAKhanZMThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review: Compliance in cardiovascular diseaseInt J Clin Pract2007621768717983433
  • RasmussenJNChongAAlterDARelationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarctionJAMA2007297217718617213401
  • WeidenPJKozmaCGroggALocklearJPartial compliance and risk of rehospitalization among California Medicaid patients with schizophreniaPsychiatr Serv200455888689115292538
  • SvarstadBLShiremanTISweeneyJKUsing drug claims data to assess the relationship of medication adherence with hospitalization and costsPsychiatr Serv200152680581111376229
  • MuszbekNBrixnerDBenedictAKeskinaslanAKhanZMThe economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review: Economics of noncompliance in CVDInt J Clin Pract200862233835118199282
  • SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
  • LeeTHEulogy for a Quality MeasureN Engl J Med2007357121175117717881749
  • SteinerJFProchazkaAVThe assessment of refill compliance using pharmacy records: methods, validity, and applicationsJ Clin Epidemiol19975011051169048695
  • AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf200615856557416514590
  • BennerJSLong-term persistence in use of statin therapy in elderly patientsJAMA2002288445512132975
  • HamiltonRABricelandLLUse of prescription-refill records to assess patient complianceAm J Hosp Pharm1992497169116961621725
  • KarveSClevesMAHelmMHudsonTJWestDSMartinBCProspective validation of eight different adherence measures for use with administrative claims data among patients with schizophreniaValue Health200912698999519402852
  • HessLMRaebelMAConnerDAMaloneDCMeasurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresAnn Pharmacother2006407–81280128816868217
  • LamWYFrescoPMedication adherence measures: an overviewBioMed Res Int20152015112
  • HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064761039104816651464
  • ChoudhryNKShrankWHLevinRLMeasuring concurrent adherence to multiple related medicationsAm J Manag Care200915745746419589013
  • MartinBCWiley-ExleyEKRichardsSDominoMECareyTSSleathBLContrasting measures of adherence with simple drug use, medication switching, and therapeutic duplicationAnn Pharmacother2009431364419126828
  • FranklinJMShrankWHPakesJGroup-based trajectory models: a new approach to classifying and predicting long-term medication adherenceMed Care201351978979623685406
  • KozmaCDicksonMPhillipsALMeleticheDMMedication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosisPatient Prefer Adherence2013750951623807840
  • KarveSClevesMAHelmMHudsonTJWestDSMartinBCAn empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patientsMed Care200846111125113318953222
  • ElliottWJPlauschinatCASkrepnekGHGauseDPersistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapiesJ Am Board Fam Med2007201728017204738
  • SilvaNLRibeiroENavarroJLZaniniACCompliance with treatment: related-issues and insights for pharmacist interventionBraz J Pharm Sci2011471112
  • FairmanKAEvaluating medication adherence: which measure is right for your program?J Manag Care Pharm200066499506
  • AvornJMonetteJLacourAPersistence of use of lipid-lowering medications: a cross-national studyJAMA199827918145814629600480
  • BlandfordLAnalyzing variations in medication compliance related to individual drug, drug class, and prescribing physicianJ Manag Care Pharm1999514751